Skip to main content

Market Overview

Dicerna Pharmaceuticals: Q3 Earnings Insights

Dicerna Pharmaceuticals: Q3 Earnings Insights


Dicerna Pharmaceuticals (NASDAQ:DRNA) reported its Q3 earnings results on Tuesday, November 9, 2021 at 08:00 AM.

Here's what investors need to know about the announcement.


Dicerna Pharmaceuticals their estimated earnings by 52.17%, reporting an EPS of $-0.22 versus an estimate of $-0.46, which surprised analysts.

Revenue was up $14,079,000 from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.94, which was followed by a 6.88% drop in the share price the next day.

Here's a look at Dicerna Pharmaceuticals's past performance:


Quarter Q2 2021 Q1 2021 Q4 2020 Q3 2020
EPS Estimate 0.41 -0.37 -0.03 -0.20
EPS Actual -0.53 -0.39 -0.49 -0.29
Revenue Estimate 91.29M 46.28M 67.25M 51.50M
Revenue Actual 41.34M 47.60M 40.96M 48.88M

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.


Related Articles (DRNA)

View Comments and Join the Discussion!

Posted-In: BZI-RecapsEarnings News

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at